Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

North America Pharmaceutical Contract Research Organization CRO Market

North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity
Report code: SDMRHE1550917 | Industry: Healthcare and Social Assistance | Published On: 44194
 Sample & Brochure   Talk to Analyst   Request Customization  Make an enquiry   Discount

North America pharmaceutical CRO market is expected to grow by 7.3% annually in the forecast period and reach $37.61 billion by 2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 26 tables and 41 figures, this 106-page report “North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services

Based on Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America pharmaceutical CRO market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co Ltd
ICON Plc
IQVIA Holdings Inc.
LSK North America Pharma Service Co Ltd
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co. Ltd
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table  of  Contents
1  Introduction 6
1.1  Industry  Definition  and  Research  Scope 6
1.1.1  Industry  Definition 6
1.1.2  Research  Scope 7
1.2  Research  Methodology 10
1.2.1  Overview  of  Market  Research  Methodology 10
1.2.2  Market  Assumption 11
1.2.3  Secondary  Data 11
1.2.4  Primary  Data 11
1.2.5  Data  Filtration  and  Model  Design 13
1.2.6  Market  Size/Share  Estimation 14
1.2.7  Research  Limitations 15
1.3  Executive  Summary 16
2  Market  Overview  and  Dynamics 19
2.1  Market  Size  and  Forecast 19
2.1.1  Impact  of  COVID-19  on  World  Economy 20
2.1.2  Impact  of  COVID-19  on  the  Market 23
2.2  Major  Growth  Drivers 25
2.3  Market  Restraints  and  Challenges 30
2.4  Emerging  Opportunities  and  Market  Trends 33
2.5  Porter’s  Fiver  Forces  Analysis 37
3  Segmentation  of  North  America  Market  by  Service 41
3.1  Market  Overview  by  Service 41
3.2  CRO  for  Pre-clinical  Development 43
3.3  CRO  for  Phase  I  Trials 44
3.4  CRO  for  Phase  II  Trials 45
3.5  CRO  for  Phase  III  Trials 46
3.6  CRO  for  Phase  IV  Trials 47
3.7  Laboratory  Services 48
3.8  Consulting  Services 49
3.9  Data  Management  Services 50
4  Segmentation  of  North  America  Market  by  Therapeutic  Application 51
4.1  Market  Overview  by  Therapeutic  Application 51
4.2  Infectious  Diseases 53
4.3  Oncology 54
4.4  Metabolic  Disorders 55
4.5  Cardiovascular  Disorders 56
4.6  Central  Nervous  System 57
4.7  Respiratory  Disorders 58
4.8  Gastrointestinal  Disorders 59
4.9  Other  Therapeutic  Applications 60
5  Segmentation  of  North  America  Market  by  End  User 61
5.1  Market  Overview  by  End  User 61
5.2  Pharmaceutical  &  Biopharmaceutical  Companies 63
5.3  Medical  Device  Companies 64
5.4  Academic  Institutes 65
6  North  America  Market  2019-2030  by  Country 67
6.1  Overview  of  North  America  Market 67
6.2  U.S. 70
6.3  Canada 74
6.4  Mexico 76
7  Competitive  Landscape 78
7.1  Overview  of  Key  Vendors 78
7.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 82
7.3  Company  Profiles 83
Charles  River  Laboratories 83
CMIC  Co.  Ltd 85
Covance  Inc. 86
Hangzhou  Tigermed  Consulting  Co  Ltd 87
ICON  Plc 88
IQVIA  Holdings  Inc. 89
LSK  North  America  Pharma  Service  Co  Ltd 90
Novotech  Pty  Ltd 91
PAREXEL  International  Corporation 92
Pharmaceutical  Product  Development  LLC  (PPD) 93
PRA  Health  Sciences  Inc. 94
Quanticate  Ltd 95
Samsung  Bioepis  Co.  Ltd 96
SGS  SA  (SGS  Life  Sciences) 97
Syneos  Health  Inc. 98
WuXi  AppTec  Inc. 99
8  Investing  in  North  America  Market:  Risk  Assessment  and  Management 100
8.1  Risk  Evaluation  of  North  America  Market 100
8.2  Critical  Success  Factors  (CSFs) 103
Related  Reports  and  Products 106
Table 1. Snapshot of North America Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World Real GDP, 2017-2021 21
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27
Table 4. Worldwide Total Number of Registered Clinical Trials 29
Table 5. Main Product Trends and Market Opportunities in North America Pharmaceutical CRO Market 33
Table 6. North America Pharmaceutical CRO Market by Service, 2019-2030, $ bn 41
Table 7. North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 51
Table 8. North America Pharmaceutical CRO Market by End User, 2019-2030, $ bn 61
Table 9. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn 68
Table 10. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn 72
Table 11. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 72
Table 12. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn 72
Table 13. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn 75
Table 14. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 75
Table 15. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn 75
Table 16. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn 77
Table 17. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 77
Table 18. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn 77
Table 19. Breakdown of North America Market by Key Vendor, 2019, % 80
Table 20. Charles River Laboratories: Company Snapshot 83
Table 21. Charles River Laboratories: Business Segmentation 83
Table 22. Charles River Laboratories: Product Portfolio 84
Table 23. Charles River Laboratories: Revenue, 2016-2018, $ bn 84
Table 24. Charles River Laboratories: Recent Developments 84
Table 25. Risk Evaluation for Investing in North America Market, 2019-2030 101
Table 26. Critical Success Factors and Key Takeaways 104
 Feel free to contact us

 
Choose License Type
Select User Type


Report code


Buy Now

x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT